Cingulate Inc (CING)
0.8801
+0.04
(+4.77%)
USD |
NASDAQ |
Apr 26, 16:00
0.8946
+0.01
(+1.65%)
After-Hours: 20:00
Cingulate Cash from Operations (TTM): -15.03M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -15.03M |
September 30, 2023 | -16.68M |
June 30, 2023 | -15.79M |
March 31, 2023 | -15.59M |
December 31, 2022 | -15.88M |
Date | Value |
---|---|
September 30, 2022 | -16.30M |
June 30, 2022 | -15.48M |
March 31, 2022 | -12.62M |
December 31, 2021 | -10.43M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-16.68M
Minimum
Sep 2023
-10.43M
Maximum
Dec 2021
-14.87M
Average
-15.59M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
FibroGen Inc | -315.02M |
Genprex Inc | -24.74M |
Tyra Biosciences Inc | -50.14M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |